The Christie NHS Foundation Trust
Director of Pharmacy
Rob Duncombe. Director of Pharmacy at the Christie NHS Foundation Trust in Manchester. A member of a number of national groups associated with pharmacy practice and medicines optimisation. Closely involved in recent initiates in the UK around the introduction of biosimilars in cancer; national dose banding of chemotherapy; and a radical approach to managing oral chemotherapy treatments.
Medicine Optimisation in Oncology. How to achieve best value.
Expenditure on the drugs we use in cancer is increasing every year. This is a function of both demographics and a paradigm shift in how we treat cancer. It is therefore extremely important that we optimise the use of cancer medicines and eliminate waste.
EVEN MORE SEMINARS
Professor Patricia Price Action Radiotherapy
Action Radiotherapy -a charity for radiotherapy patients and professionals.
Cheng Boon Worcestershire Royal Hospital
Consultant Clinical Oncologist, GI and Head & Neck
Dr Christy Goldsmith Action Radiotherapy
Improving patient outcomes with Stereotactic Ablative Body Radiotherapy (SABR)
Prof Adam Waldman MRC Institute of Genetics & Molecular Medicine CANCER RESEARCH UK Imaging
Biomarkers in Adult Glioma
Mohamed Torky Hospital Germans Trias i pujol. Barcelona. Spain
Role of Radial-EBUS in diagnosis of lung cancer.